Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
RWHAP Part C and D Stakeholders Webinar - July 2021
Session covered program updates and Centering Care for Women, Children, and Adolescents across the HIV Care Continuum.Resource updated 01/10/2024
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
2021 Quality Award Winners Webinar
Winners of the CQII Quality of Care Awards in 2021, showcasing their work to assist Ryan White HIV/AIDS Program recipients in gaining insight into exemplary quality improvement and leadership efforts.Resource updated 08/17/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Bilingual and Bicultural Care Team
Hispanic and Latino clients served by the team received culturally responsive care and linkages to external community resources, with resulting greater retention in care and improved viral suppression rates.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
-
FY23 RWHAP Part A Non-Competing Continuation Progress Report
FY2023 Ryan White HIV/AIDS Program (RWHAP) Part A Non-Competing Continuation Progress Report.Resource updated 09/19/2023
-
Integration of Oral Health and Primary Care in Seattle-King County
This referral-based oral health model used dental navigators to connect clients to a large network of dentists, which facilitated scheduling of appointments.Resource from the RWHAP Best Practices Compilation updated on 11/02/2023
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
RWHAP Part C and D Stakeholders Webinar - April 2022
Session covered program updates and program income (current practices from the field).Resource updated 01/10/2024
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible is the name of a new, national campaign to encourage and energize the HIV workforce to achieve the national goal of ending the HIV epidemic.Blog updated 06/30/2022
-
Routine Universal Screening for HIV (RUSH)
Routine Universal Screening for HIV (RUSH) provides non-medical case management services, opt-out HIV testing, and linkage to care for emergency department patients. The intervention automatically screens patients for HIV if they are aged 16 years or older, are having an IV inserted, or are having blood drawn for other reasons, unless the patient opts out. RUSH provides access to testing earlier in disease progression, bridging disparities that primarily impact people of color. It also promotes linkage to and retention in care for those with a positive HIV test result. Clients with a positive HIV test in the emergency department who had a prior diagnosis of HIV were more likely to be retained in care and to reach viral suppression.Resource from the RWHAP Best Practices Compilation updated on 02/02/2024
-
Imagine: Ending HIV. It's Possible.
Kickoff of a national campaign to showcase how RWHAP leaders have been innovating to achieve the goal of ending the HIV epidemic.Resource updated 03/15/2023
-
Sustaining Outcomes and Programs - 2022
Review of ways to sustain the gains made in an agency's quality improvement efforts and make them part of the organization’s culture.Resource updated 08/17/2023
-
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers.Resource updated 09/19/2023
-
National Monitoring Standards for RWHAP Part A Recipients
This HRSA technical assistance webinar was to provide a high level overview of updates made to the National Monitoring Standards (NMS). Release of the NMS is forthcoming.Resource updated 08/21/2023